G21 Launches SpaceFlex Trials Kit for Joint Infection

G21 completed its line of custom-modular spacers with the introduction of the new SpaceFlex r-evolution™ trials kit line.

Filippo Foroni, Executive Vice President of G21, said, “With the SpaceFlex system and our complete line of cements, we offer the only modular mold system currently available on the market for the treatment of joint infections in orthopaedics. Trials have further enhanced our exclusive modularity studied on the patient’s anatomy in order to perform guided and intuitive surgeries. Furthermore, we have optimized size selection so as to ensure proper congruence and filling, by minimizing the risk of dislocation and migration of the implant with the aid of targeted size selection.”